Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy: Progress and Pitfalls
Ad W G J Oomen1, Christopher Semsarian2, Rajesh Puranik3
1Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition causing sudden cardiac death. Diagnosing ARVC is challenging due to a lack of specific indicators, requiring multiple tests for confirmation.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited condition affecting the right ventricle.
- It is a significant cause of sudden cardiac death in young individuals and athletes.
- Current diagnostic methods for ARVC present considerable challenges.
Purpose of the Study:
- To highlight the complexities in diagnosing Arrhythmogenic right ventricular cardiomyopathy (ARVC).
- To review the current international task force criteria for ARVC diagnosis.
- To identify limitations and suggest future improvements for ARVC diagnostic protocols.
Main Methods:
- Review of current international task force criteria for ARVC diagnosis.
- Analysis of diagnostic modalities including imaging, histology, electrophysiology, and genetic testing.
- Discussion of the limitations of existing criteria.
Main Results:
- ARVC diagnosis relies on combining major and minor criteria across six categories.
- No single diagnostic finding is pathognomonic for ARVC.
- Current criteria have limitations in specificity, necessitating further refinement.
Conclusions:
- Diagnosing ARVC is complex and requires integrating data from various sources.
- Existing diagnostic criteria for ARVC need enhancement for improved accuracy and specificity.
- Future advancements may involve advanced imaging, electro-anatomical mapping, and genetic variant interpretation.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy that predominantly affects the right ventricle. With a prevalence in the range of 1:5000 to 1:2000 persons, ARVC is one of the leading causes of sudden cardiac death in young people and in athletes. Although early detection and treatment is important, the diagnosis of ARVC remains challenging. There is no single pathognomonic diagnostic finding in ARVC; rather, current international task force criteria specify diagnostic major and minor criteria in six categories: right ventricular imaging (including echocardiography and cardiac magnetic resonance imaging (MRI)), histology, repolarisation abnormalities, depolarisation and conduction abnormalities, arrhythmias and family history (including genetic testing). Combining findings from differing diagnostic modalities can establish a "definite", "borderline" or "possible" diagnosis of ARVC. However, there are limitations inherent in the current task force criteria, including the lack of specificity for ARVC; future iterations may be improved, for example, by enhanced imaging protocols able to detect subtle changes in the structure and function of the right ventricle, incorporation of electro-anatomical data, response to adrenergic challenge, and validated criteria for interpreting genetic variants.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management


